HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis.

Abstract
Cytokine control of the synovial infiltrate is a central process in the development of inflammatory arthritis. In this study, we combine genetic approaches and intervention strategies to describe a fundamental requirement for IL-6-mediated STAT3 signaling in orchestrating the inflammatory infiltrate in monoarticular and systemic models of experimental arthritis. STAT3 activation via the common gp130 signal-transducing receptor for all IL-6-related cytokines led to increased retention of neutrophils and T cells within the inflamed synovium, which included STAT3-regulated IL-17A-secreting T cells. Control of leukocyte infiltration was reliant upon IL-6 signaling via its soluble receptor (termed IL-6 trans signaling), as evidenced by selective blockade of this alternative IL-6 signaling pathway using an engineered variant of soluble gp130 (sgp130Fc). This therapeutic intervention led to substantial clinical improvement in mice with emerging or established incidence of systemic arthritis. These data illustrate that IL-6 control of STAT3 is critical for regulating the synovial infiltrate in inflammatory arthritis, and suggest that selective inhibition of IL-6 trans signaling may provide a more refined intervention strategy for blocking IL-6-driven proarthritic activities.
AuthorsMari A Nowell, Anwen S Williams, Sarah A Carty, Jürgen Scheller, Anthony J Hayes, Gareth W Jones, Peter J Richards, Simon Slinn, Matthias Ernst, Brendan J Jenkins, Nicholas Topley, Stefan Rose-John, Simon A Jones
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 182 Issue 1 Pg. 613-22 (Jan 01 2009) ISSN: 1550-6606 [Electronic] United States
PMID19109195 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Il6st protein, mouse
  • Inflammation Mediators
  • Interleukin-6
  • Recombinant Fusion Proteins
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Cytokine Receptor gp130
  • olamkicept
Topics
  • Animals
  • Arthritis, Experimental (immunology, pathology, therapy)
  • CHO Cells
  • Cells, Cultured
  • Cricetinae
  • Cricetulus
  • Cytokine Receptor gp130 (genetics, physiology)
  • Humans
  • Inflammation Mediators (metabolism, physiology)
  • Interleukin-6 (deficiency, genetics, metabolism, physiology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mice, Knockout
  • Mice, Transgenic
  • Recombinant Fusion Proteins (biosynthesis, genetics, physiology)
  • Recurrence
  • STAT3 Transcription Factor (antagonists & inhibitors, metabolism, physiology)
  • Signal Transduction (genetics, immunology)
  • Synovial Membrane (immunology, metabolism, pathology)
  • T-Lymphocytes (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: